Artemis Medicare Services recommends ₹0.45 dividend; TDS details for FY25-26 announced
Artemis Medicare Services recommended a final dividend of ₹0.45 per equity share for FY 2025-26. The record date is July 10, 2026. Shareholders must provide updated tax-related documents by July 15, 2026, to determine TDS rates. Non-residents can avail DTAA benefits with proper documentation.
This is a routine communication about dividend payment and TDS procedures, which is a standard practice for listed companies. It does not introduce new business strategies, financial performance changes, or significant operational updates that would materially impact the company.
The announcement is a standard communication regarding dividend payment and associated tax regulations, providing necessary information to shareholders without indicating a significant positive or negative development for the company.
Artemis Medicare Services Limited has informed its shareholders about the applicable provisions of the Income-tax Act, 2025, concerning Tax Deduction at Source (TDS) on the final dividend for FY 2025-26. The Board of Directors, in a meeting held on May 8, 2026, recommended a final dividend of ₹0.45 per equity share of face value ₹1 each.
The record date for dividend entitlement has been set for Friday, July 10, 2026. The final dividend, if approved by shareholders at the 22nd Annual General Meeting (AGM), will be paid within 30 days of the AGM.
The company outlined the TDS rates for resident shareholders, with a standard rate of 10% for those furnishing a valid PAN, and 20% for those without or with an invalid PAN. Resident individuals submitting Form 121 may be exempt, and specific rates apply to insurance companies and other entities like Mutual Funds and Government bodies. A threshold of ₹10,000 for total dividend in FY 2026-27 exempts resident individual shareholders from TDS.
For non-resident shareholders, the withholding tax is generally 20% plus applicable surcharge and cess. However, they can opt for beneficial Double Taxation Avoidance Agreement (DTAA) rates by providing necessary documentation, including a Tax Residency Certificate (TRC) and Form 41.
Shareholders are urged to update their PAN, bank account details, and other contact information with the company's Registrar and Transfer Agent, Alankit Assignments Limited, by Wednesday, July 15, 2026, to ensure timely dividend payment and correct TDS deduction. No claims regarding tax determination will be entertained after this date.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.